Autor(es): Tsetsarkin Konstantin A, Chen Rubing, Weaver Scott C

Resumo: Chikungunya virus (CHIKV) causes severe, debilitating, often chronic arthralgia with high attack rates, resulting in severe morbidity - economic costs to affected communities. Since its first well-documented emergence in Asia in the 1950s, CHIKV has infected millions -, since 2007, has spread widely, probably via viremic travelers, to initiate urban transmission in Europe, the South Pacific, - the Americas. Some spread has been facilitated by adaptive envelope glycoprotein substitutions that enhance transmission by the new vector, Aedes albopictus. Although epistatic constraints may prevent the impact of these mutations in Asian strains now circulating in the Americas, as well as in African CHIKV strains imported into Brazil last year, these constraints could eventually be overcome over time to increase the transmission by A. albopictus in rural - temperate regions. Another major determinant of CHIKV endemic stability in the Americas will be its ability to spill back into an enzootic cycle involving sylvatic vectors - nonhuman primates, an opportunity exploited by yellow fever virus but apparently not by dengue viruses.

Imprenta: Current Opinion in Virology, v. 16, p. 143-150, 2016

Identificador do objeto digital: 10.1016/j.coviro.2016.02.007

Descritores: Chikungunya virus - Cytopathology ; Chikungunya virus - Infectious diseases ; Chikungunya virus - Viral infections ; Chikungunya Virus - Virus ; Chikungunya virus - Transmission ; Chikungunya virus - Chikungunya fever ; Chikungunya virus - Dengue ; Chikungunya virus - Immunology

Data de publicação: 2016

INDICADORES

ACESSO